Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management

Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) ...
ascopubs.org

Disruptive Analysis of Total Neoadjuvant Therapy in Locally Advanced Rectal Cancer: Clinical and Therapeutic Distinctions Between Low- and Mid-Rectal Cancers

Development of a Classifier for Metabolic Subtypes of Nasopharyngeal Carcinoma to Guide Personalized Immunotherapy Strategies: Biomarker Analysis of the Phase III CONTINUUM and DIPPER Trials Total ...
The New England Journal of Medicine

Belzutifan versus Everolimus for Advanced Renal-Cell Carcinoma

Belzutifan, a hypoxia-inducible factor 2α inhibitor, showed clinical activity in clear-cell renal-cell carcinoma in early-phase studies. In a phase 3, multicenter, open-label, active-controlled trial, ...
ascopubs.org

Belzutifan in patients with advanced clear cell renal cellcarcinoma (ccRCC): Subgroup analysis of the phase 2 LITESPARK-013 study.

Matched tissue and circulating tumor DNA (ctDNA) analysis in renal cell carcinoma (RCC): Results from a multimodal real-world database. Health-related quality of life (HRQoL) with nivolumab (NIVO) ...